Question 1

What is alpha-1 antitrypsin deficiency and what causes it?

Accepted Answer

Alpha-1 antitrypsin deficiency (AATD) is a genetic condition where the body doesn’t produce enough alpha-1 antitrypsin, a protein that protects the lungs and liver. It’s caused by inherited mutations in the SERPINA1 gene passed down from one or both parents.
Reference

Question 2

How does alpha-1 antitrypsin deficiency affect the lungs and liver?

Accepted Answer

In the lungs, low alpha-1 levels can lead to damage from enzymes, causing conditions like emphysema or COPD. In the liver, abnormal alpha-1 buildup can result in inflammation, fibrosis, or cirrhosis over time, even in children.
Reference

Question 3

What diseases are linked to alpha-1 antitrypsin deficiency?

Accepted Answer

AATD is most commonly associated with chronic obstructive pulmonary disease (COPD), emphysema, and chronic liver disease. Some individuals may also develop bronchiectasis or liver cirrhosis without smoking or alcohol risk factors.

Question 4

What are the symptoms and how is it diagnosed?

Accepted Answer

Symptoms may include shortness of breath, wheezing, unexplained liver issues, or fatigue. Diagnosis is done through blood tests that check alpha-1 levels and genetic testing to confirm the condition.

Question 5

Can alpha-1 antitrypsin deficiency skip a generation or be inherited?

Accepted Answer

Yes, AATD is inherited in an autosomal codominant pattern. A person must inherit abnormal genes from one or both parents. Carriers may show no symptoms, which can make it seem like it skips generations.

Question 6

What is the life expectancy for someone with alpha-1 antitrypsin deficiency?

Accepted Answer

Life expectancy varies based on severity, lifestyle factors, and early diagnosis. Many individuals live a normal lifespan, especially with proper management and avoidance of smoking or lung irritants.

Question 7

Can alpha-1 antitrypsin deficiency be treated or managed?

Accepted Answer

While there is no cure, AATD can be managed through lifestyle changes, medications to support lung function, and in some cases, alpha-1 augmentation therapy. Regular monitoring of lung and liver health is important.

Question 8

What medications or triggers should be avoided with this condition?

Accepted Answer

People with AATD should avoid smoking, secondhand smoke, excessive alcohol, and medications that stress the liver. Always consult a healthcare provider before starting or stopping any treatment.

Question 9

Who should get tested for alpha-1 antitrypsin deficiency?

Accepted Answer

Testing is recommended for individuals with early-onset COPD, unexplained liver disease, a family history of AATD, or chronic lung issues without typical risk factors like smoking.

Question 10

Is alpha-1 antitrypsin deficiency considered a rare disease or a disability?

Accepted Answer

Yes, AATD is classified as a rare genetic disorder. In severe cases that impact daily functioning, it may be recognized as a disability under U.S. guidelines, especially if it leads to advanced lung or liver disease.

Alpha 1 Antitrypsin Deficiency Medications